The Incidence and Predictive Factors of Thromboembolism During Hospitalizations for Inflammatory Bowel Disease Flare‐Ups: A Retrospective Cohort Study in Taiwan
Journal of Evaluation in Clinical Practice · 2025
DOI: 10.1111/jep.14231 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Evaluation in Clinical Practice, 2025. Verfasst von Ming-Jung Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Thromboembolism, Inflammatory Bowel Diseases, Hospitalization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background/Aims Thromboembolism (TE) notably increase morbidity and mortality among inflammatory bowel disease (IBD) patients. Despite ECCO's 2024 guidelines advocating routine anticoagulant prophylaxis, its application in Asia remains inconsistent due to a lack of regional studies. This research investigates the incidence and predictors of TE during IBD‐related hospitalizations in Taiwan, aiming to improve prevention strategies. Materials and Methods Our retrospective cohort study included 282 adult IBD patients, accounting for 515 flare‐up related hospitalizations at Linkou Chang Gung Memorial Hospital from January 2001 to March 2024. Patients were classified into two groups based on the occurrence of TE.
Results
The incidence of TE was 1.55%. The TE group had significantly lower body weight, body mass index (BMI), hemoglobin and albumin levels but higher rate of sepsis and concurrent autoimmune diseases compared to the non‐TE group. Multivariate analysis indicated that concurrent autoimmune diseases and hypoalbuminemia were independent predictors of TE. The optimal serum albumin cutoff was established at 3.01 g/dL, with sensitivities and specificities of 87.5% and 77.3%, respectively.
Conclusions
This pioneering Asian study identifies concurrent autoimmune diseases and low serum albumin as key predictors of TE in hospitalized IBD patients. We recommend targeted anticoagulant prophylaxis for IBD patients with these risk factors, especially when serum albumin falls below 3.01 g/dL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
- College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
- Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
- MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.
- Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
ORCID-Profile: Ming-Jung Meng, Chen-Shuan Chung, Chen-Wang Chang, Yu-Bin Pan, Chia-Jung Kuo, Cheng-Tang Chiu, Puo-Hsien Le
Zitieren
APA
Meng, M. J., Chung, C. S., Chang, C. W., Pan, Y. B., Kuo, C. J., Chiu, C. T., & Le, P. H. (2025). The Incidence and Predictive Factors of Thromboembolism During Hospitalizations for Inflammatory Bowel Disease Flare‐Ups: A Retrospective Cohort Study in Taiwan. Journal of Evaluation in Clinical Practice. https://doi.org/10.1111/jep.14231
Vancouver
Meng MJ, Chung CS, Chang CW, Pan YB, Kuo CJ, Chiu CT, et al. The Incidence and Predictive Factors of Thromboembolism During Hospitalizations for Inflammatory Bowel Disease Flare‐Ups: A Retrospective Cohort Study in Taiwan. Journal of Evaluation in Clinical Practice. 2025. doi:10.1111/jep.14231
BibTeX
@article{Meng2025,
author = {Meng, Ming-Jung and Chung, Chen-Shuan and Chang, Chen-Wang and Pan, Yu-Bin and Kuo, Chia-Jung and Chiu, Cheng-Tang and Le, Puo-Hsien},
title = {The Incidence and Predictive Factors of Thromboembolism During Hospitalizations for Inflammatory Bowel Disease Flare‐Ups: A Retrospective Cohort Study in Taiwan},
journal = {Journal of Evaluation in Clinical Practice},
year = {2025},
doi = {10.1111/jep.14231}
}
EUVIMED